Cargando…
Combined inhibition of ACLY and CDK4/6 reduces cancer cell growth and invasion
The use of small molecule kinase inhibitors, which target specific enzymes that are overactive in cancer cells, has revolutionized cancer patient treatment. To treat some types of breast cancer, CDK4/6 inhibitors, such as palbociclib, have been developed that target the phosphorylation of the retino...
Autores principales: | Velez, Brian Christopher, Petrella, Christopher Paul, DiSalvo, Kathleen Helen, Cheng, Keyi, Kravtsov, Rebecca, Krasniqi, Dorina, Krucher, Nancy Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827262/ https://www.ncbi.nlm.nih.gov/pubmed/36562384 http://dx.doi.org/10.3892/or.2022.8469 |
Ejemplares similares
-
Interest groups, local politics, and police unions
por: DiSalvo, Daniel
Publicado: (2022) -
Automated sensing and splitting of stem cell colonies on microraft arrays
por: DiSalvo, Matthew, et al.
Publicado: (2019) -
RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells
por: Yamazoe, Sadaaki, et al.
Publicado: (2010) -
Phosphorylation of the Retinoblastoma protein (Rb) on serine-807 is required for association with Bax
por: Antonucci, Lisa A, et al.
Publicado: (2014) -
The interplay of CDK4 and CDK6 in melanoma
por: Kollmann, Karoline, et al.
Publicado: (2019)